Mayo Clinic in Rochester is a member of the Cancer Prevention Network (CPN) and is participating in a national research study on lung cancer prevention. You may be eligible to participate in this research study if you:
What does this study involve?
This research study involves physical exams, ECGs, bronchoscopies, blood and urine tests, a chest CT scan, and taking the study medication Myo-Inositol (or placebo) twice a day for six months.
What is Myo-Inositol?
Myo-Inositol is a natural substance found in grains, seeds, and fruits.
Are there any risks involved?
If you choose to participate, you will be at risk for side effects from the medication and bronchoscopy procedure. Common side effects following bronchoscopy are coughing, sore throat, small streaks of blood in sputum, and mild elevation of temperature.
Will I get any benefit from being in the study?
If you agree to be in this study, there may or may not be any direct medical benefit to you. We hope what we learn from this study will benefit others at risk for lung cancer in the future.
Who can I contact for more information?
If you have questions, please call 507-538-1887.
This study is funded by the National Cancer Institute and conducted by the Cancer Prevention Network. CPN has more than 35 sites throughout the United States and Canada. Our goal is to learn how to prevent cancer before it starts.
There may be a CPN site close to you, so call now and become involved in a clinical research study today.
Tags: About, cancer, Cancer Prevention Network, clinical research, clinical trial, clinical trials, Dr. David Midthun, Findings, Innovations, lung, Mayo Clinic research, medical research, myo-inositol, National Cancer Institute, People, pulmonary, research, research study, respiratory, Science, study, Uncategorized